Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 216493
Company: HANGZHOU ZHONGMEI
Company: HANGZHOU ZHONGMEI
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| FONDAPARINUX SODIUM | FONDAPARINUX SODIUM | 2.5MG/0.5ML (2.5MG/0.5ML) | SOLUTION;SUBCUTANEOUS | Discontinued | None | No | No |
| FONDAPARINUX SODIUM | FONDAPARINUX SODIUM | 5MG/0.4ML (5MG/0.4ML) | SOLUTION;SUBCUTANEOUS | Discontinued | None | No | No |
| FONDAPARINUX SODIUM | FONDAPARINUX SODIUM | 7.5MG/0.6ML (7.5MG/0.6ML) | SOLUTION;SUBCUTANEOUS | Discontinued | None | No | No |
| FONDAPARINUX SODIUM | FONDAPARINUX SODIUM | 10MG/0.8ML (10MG/0.8ML) | SOLUTION;SUBCUTANEOUS | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 08/19/2024 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |